D-1178-2022 Class II Ongoing
FDA drug recall D-1178-2022 was initiated by Golden State Medical Supply Inc. on Mar 16, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 9,058.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 13, 2022
- Initiation Date
- Mar 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,058
Product description
Enalapril Maleate Tablets, USP; 5 mg; 90 tablets, NDC 60429-184-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
Code information
Lot: GS029041, GS029353, GS02986, 5 mg; 90 tablets, Exp.: 09/2022; Lot: GS030056, GS030869, GS033943, Exp.: 10/2022; Lots: GS034490, GS035197, Exp.:02/2023; Lots: GS035198, Exp.: 03/2023; Lots: GS035596, GS035947, GS036759, GS037400, Exp.: 06/2023; Lots: GS038089, GS038763, GS039559, GS040150, Exp.: 10/2023; Lots: GS040151, GS040708, GS041107, Exp.: 12/2023; Lot: GS041654, Exp.: 03/2024.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1178-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026